Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations

Abstract

Outdoor air pollution is a major contributor to the burden of disease worldwide. Most of the global population resides in places where air pollution levels, because of emissions from industry, power generation, transportation, and domestic burning, considerably exceed the World Health Organization's health-based air-quality guidelines. Outdoor air pollution poses an urgent worldwide public health challenge because it is ubiquitous and has numerous serious adverse human health effects, including cancer. Currently, there is substantial evidence from studies of humans and experimental animals as well as mechanistic evidence to support a causal link between outdoor (ambient) air pollution, and especially particulate matter (PM) in outdoor air, with lung cancer incidence and mortality. It is estimated that hundreds of thousands of lung cancer deaths annually worldwide are attributable to PM air pollution. Epidemiological evidence on outdoor air pollution and the risk of other types of cancer, such as bladder cancer or breast cancer, is more limited. Outdoor air pollution may also be associated with poorer cancer survival, although further research is needed. This report presents an overview of outdoor air pollutants, sources, and global levels, as well as a description of epidemiological evidence linking outdoor air pollution with cancer incidence and mortality. Biological mechanisms of air pollution-derived carcinogenesis are also described. This report concludes by summarizing public health/policy recommendations, including multilevel interventions aimed at individual, community, and regional scales. Specific roles for medical and health care communities with regard to prevention and advocacy and recommendations for further research are also described.

Recent Application of Zebrafish Models in Atherosclerosis Research

“…According to WHO statistics, outdoor air pollution, such as fine particulate matter with a diameter ≤2.5 µm (PM2.5), causes approximately 3.7 million deaths every year. Long-term exposure to high concentrations of PM2.5 increases the risk of cardiovascular diseases and cancers (Kloog et al, 2013;Dabass et al, 2016;Turner et al, 2020). PM2.5 has been previously reported to cause disorders in zebrafish lipid metabolism (Kim et al, 2015).…”

Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy

“…Malignant melanoma, the major fatal form of skin cancer, accounts for more than 90% of all skin cancer-related deaths (Miller et al., 2020 ; Siegel et al., 2020 ). Although genetic susceptibility and skin pigmentation are dominant risk factors, environmental factors such as occupation and latitude have been identified to affect the morbidity and motility of melanoma (Turner et al., 2020 ). An estimated 100,350 new cases of skin melanoma will be diagnosed at the end of 2020, which will lead to a nearly 6.8% incidence of death (Siegel et al., 2020 ).…”

Nanocarrier-Based Drug Delivery for Melanoma Therapeutics

“…Cutaneous melanoma is a type of skin cancer whose incidence is increasing significantly worldwide [ 1 , 2 , 3 ]. Although melanoma occurs infrequently, accounting for less than 5% of skin cancer, it is highly aggressive and accounts for more than 75% of all skin cancer deaths [ 4 , 5 , 6 , 7 , 8 ]. Furthermore, melanoma is the third most common source of brain metastases after lung and breast cancer, with more than 60% of patients with metastatic melanoma having or developing brain metastases during their onset [ 9 ].…”